{"id":"https://openalex.org/W72689180","doi":null,"title":"[Irbesartan in hypertensive non-diabetic advanced chronic kidney disease. Comparative study with ACEI].","display_name":"[Irbesartan in hypertensive non-diabetic advanced chronic kidney disease. Comparative study with ACEI].","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W72689180","mag":"72689180","pmid":"https://pubmed.ncbi.nlm.nih.gov/18336132"},"language":"es","primary_location":{"id":"pmid:18336132","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18336132","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080548314","display_name":"Francisco Coronel","orcid":"https://orcid.org/0000-0002-8340-948X","observed_orcids":["https://orcid.org/0000-0002-8340-948X"]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"F Coronel","raw_affiliation_strings":["Servicio de Nefrolog\u00eda, Hospital Cl\u00ednico San Carlos, Madrid. fcoronel.hcsc@salud.madrid.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Nefrolog\u00eda, Hospital Cl\u00ednico San Carlos, Madrid. fcoronel.hcsc@salud.madrid.org","institution_ids":["https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044207981","display_name":"Secundino Cigarr\u00e1n","orcid":"https://orcid.org/0000-0001-5624-2605","observed_orcids":["https://orcid.org/0000-0001-5624-2605"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Cigarr\u00e1n","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048256280","display_name":"Mercedes Garc\u00eda-Mena","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Garc\u00eda-Mena","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J A Herrero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J A Herrero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"N Calvo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Calvo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5063273123","display_name":"Isabel P\u00e9rez-Flores","orcid":"https://orcid.org/0000-0003-4644-1277","observed_orcids":["https://orcid.org/0000-0003-4644-1277"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I P\u00e9rez-Flores","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0812,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.78986958,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"28","issue":"1","first_page":"56","last_page":"60"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.044599998742341995,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/irbesartan","display_name":"irbesartan","score":0.9860000014305115},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9399999976158142},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/advanced-chronic-kidney-disease","display_name":"advanced chronic kidney disease","score":0.8920000195503235},{"id":"https://openalex.org/keywords/non-diabetic-patients","display_name":"non-diabetic patients","score":0.8080000281333923},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6869999766349792},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.7369999885559082},{"id":"https://openalex.org/keywords/blood-pressure-control","display_name":"blood pressure control","score":0.777999997138977},{"id":"https://openalex.org/keywords/pulse-pressure","display_name":"pulse pressure","score":0.9620000123977661},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.7239999771118164},{"id":"https://openalex.org/keywords/serum-potassium","display_name":"serum potassium","score":0.8420000076293945},{"id":"https://openalex.org/keywords/serum-uric-acid","display_name":"serum uric acid","score":0.9919999837875366},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.8870000243186951},{"id":"https://openalex.org/keywords/antiproteinuric-effect","display_name":"antiproteinuric effect","score":0.765999972820282},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9217884540557861},{"id":"https://openalex.org/C2780259554","wikidata":"https://www.wikidata.org/wiki/Q947266","display_name":"Irbesartan","level":3,"score":0.6746090650558472},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.5713632702827454},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.5209890007972717},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3335517942905426},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.25066977739334106},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.08129814267158508}],"mesh":[{"descriptor_ui":"D000077405","descriptor_name":"Irbesartan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:18336132","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18336132","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","raw_type":"Clinical Trial"},{"id":"mag:72689180","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18336132","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1984546703","https://openalex.org/W1997455782","https://openalex.org/W2003670762","https://openalex.org/W2007934418","https://openalex.org/W2029624507","https://openalex.org/W2044773944","https://openalex.org/W2125958513","https://openalex.org/W2189592079","https://openalex.org/W2413195481"],"related_works":["https://openalex.org/W4413602863","https://openalex.org/W2460173387","https://openalex.org/W1981687973","https://openalex.org/W2369305980","https://openalex.org/W102024128","https://openalex.org/W4234105576","https://openalex.org/W2899291612","https://openalex.org/W2393715694","https://openalex.org/W2051950547","https://openalex.org/W2051584884"],"abstract_inverted_index":{"UNLABELLED:":[0],"Angiotensin-converting":[1],"enzyme":[2],"inhibitors":[3],"(ACEI)":[4],"have":[5,39,51],"proved":[6],"an":[7],"antihypertensive":[8],"and":[9,18,44,72,150,160,191,208,277,292,317,341],"renoprotective":[10,43],"effect":[11,237,319],"with":[12,76,143,198,220,225,232,240,304,310,325],"reduction":[13,224,259,336],"of":[14,25,171,176,203,337],"proteinuria":[15,140,144],"in":[16,28,95,169,188,196,201,206,210,216,274,280,290,294,301],"diabetic":[17,20],"non":[19],"nephropathy,":[21],"but":[22],"not":[23,272,343],"exempt":[24],"side":[26],"effects":[27,56,75],"advanced":[29,305],"chronic":[30,306,321],"kidney":[31,322],"disease":[32,323],"(ACKD)":[33],"patients.":[34,60],"Angiotensin":[35],"receptor":[36],"blockers":[37],"(ARB)":[38,67],"emerged":[40],"as":[41],"antiproteinuric,":[42],"cardioprotective":[45],"therapy.":[46],"Only":[47],"a":[48,96,199,335],"few":[49],"reports":[50],"been":[52],"published":[53],"studying":[54],"ARB":[55],"on":[57,68,320],"non-diabetic":[58,69,83],"ACKD":[59,70,86],"Our":[61],"aim":[62],"is":[63],"to":[64,186,194,244,251],"study":[65],"Irbesartan":[66,103,213,226,241,275,289,300,333],"patients":[71,84,142,303],"compare":[73],"its":[74],"ACEI.":[77],"PATIENTS":[78],"AND":[79],"METHODS:":[80],"Forty":[81],"three":[82],"at":[85,154],"stage":[87],"IV":[88],"NKF-DOQI":[89],"(CrCl":[90],"<30":[91],"ml/min)":[92],"were":[93],"enrolled":[94],"prospective":[97],"study.":[98],"Group":[99,115,172,177],"I:":[100],"21":[101],"received":[102,118],"monodose":[104],"150-300":[105],"mg/day":[106],"(63+/-17":[107],"y/o,":[108,121],"12":[109,164],"F,":[110,123],"9":[111,159],"M,ClCr":[112],"22.1+/-8":[113],"ml/m.),":[114],"II:":[116],"22":[117],"ACEI":[119,221,233,248,281,297,311],"(65+/-13":[120],"8":[122],"14":[124],"M,":[125],"CrCl":[126,223],"22.3+/-7":[127],"ml/m).":[128],"Parameters":[129],"studied:":[130],"blood":[131,314],"pressure":[132,135,315],"(BP),":[133],"pulse":[134],"(PP),":[136],"renal":[137,307],"function":[138],"(CrCl),":[139],"(in":[141],">or=":[145,266],"0.5":[146],"g/d),":[147],"serum":[148,151,338,345],"K+":[149,269,346],"uric":[152,339],"acid,":[153,340],"month":[155],"0,":[156],"3,":[157],"6,":[158],"12.":[161],"RESULTS:":[162],"At":[163],"months,":[165],"BP":[166,181,205],"was":[167,182,227,238,286],"controlled":[168],"57%":[170],"I":[173],"vs":[174,218,229],"39%":[175],"II.":[178],"Mean":[179],"systolic":[180],"decreased":[183,287],"from":[184,192],"154/85":[185],"138/77":[187],"G":[189],"I,":[190],"146/85":[193],"133/77":[195],"GII,":[197],"decrease":[200],"10.7%":[202],"mean":[204],"GI":[207],"8.5%":[209],"GII":[211],"(NS).":[212,222,234],"reduced":[214],"PP":[215],"7.2%":[217],"8.3%":[219],"0.23":[228],"0.21":[230],"ml/min/month":[231],"The":[235],"antiproteinuric":[236,327],"higher":[239,326],"(from":[242,249],"2.1":[243],"1.3":[245],"g/day)":[246],"vs.":[247],"1.35":[250],"1.33":[252],"gr":[253],"/day),":[254],"being":[255],"statistically":[256],"significant":[257],"the":[258,262,330],"percentage":[260],"between":[261],"two":[263],"groups":[264],"(p":[265],"0.041).":[267],"Serum":[268],"level":[270],"do":[271],"change":[273],"group":[276,282],"increased":[278,293],"10%":[279],"(p<0.001).":[283,298],"Uric":[284],"acid":[285],"by":[288,296],"17%":[291],"4%":[295],"CONCLUSIONS:":[299],"non-diabetics":[302],"disease,":[308],"compared":[309],"showed":[312,334],"similar":[313,318],"control":[316],"progression,":[324],"effect.":[328],"On":[329],"other":[331],"side,":[332],"did":[342],"increase":[344],"levels.":[347]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}